167 related articles for article (PubMed ID: 836748)
1. Screening for malignant hyperpyrexia.
Nelson TE; Austin KL; Denborough MA
Br J Anaesth; 1977 Feb; 49(2):169-72. PubMed ID: 836748
[TBL] [Abstract][Full Text] [Related]
2. Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.
Nelson TE; Denborough MA
Clin Exp Pharmacol Physiol; 1977; 4(3):315-22. PubMed ID: 891045
[TBL] [Abstract][Full Text] [Related]
3. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
Ginz HF; Girard T; Censier K; Urwyler A
Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
[TBL] [Abstract][Full Text] [Related]
4. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
Nelson TE; Bedell DM; Jones EW
Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
[TBL] [Abstract][Full Text] [Related]
5. Identification of susceptibility to malignant hyperpyrexia in swine.
Okumura F; Crocker BD; Denborough MA
Br J Anaesth; 1979 Mar; 51(3):171-6. PubMed ID: 435338
[TBL] [Abstract][Full Text] [Related]
6. Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine.
Sullivan JS; Denborough MA
Br J Anaesth; 1981 Nov; 53(11):1217-22. PubMed ID: 7326167
[TBL] [Abstract][Full Text] [Related]
7. In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
Ording H; Skovgaard LT
Acta Anaesthesiol Scand; 1987 Jul; 31(5):462-5. PubMed ID: 3630591
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
Hopkins PM; Ellis FR; Halsall PJ
Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
[TBL] [Abstract][Full Text] [Related]
9. Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyfort GH; Dupuis BA
Br J Anaesth; 1990 Jan; 64(1):64-6. PubMed ID: 2302378
[TBL] [Abstract][Full Text] [Related]
10. Caffeine- or halothane-induced contractures of masseter muscle are similar to those of vastus muscle in normal humans.
Melton AT; Antognini JF; Gronert GA
Acta Anaesthesiol Scand; 1999 Aug; 43(7):764-9. PubMed ID: 10456818
[TBL] [Abstract][Full Text] [Related]
11. Procaine in malignant hyperpyrexia.
Moulds RF; Denborough MA
Br Med J; 1972 Dec; 4(5839):526-8. PubMed ID: 4642792
[TBL] [Abstract][Full Text] [Related]
12. ATX II, a sodium channel toxin, sensitizes skeletal muscle to halothane, caffeine, and ryanodine.
Fletcher JE; Adnet PJ; Reyford H; Wieland SJ; Stewart SL; Rosenberg H
Anesthesiology; 1999 May; 90(5):1294-301. PubMed ID: 10319776
[TBL] [Abstract][Full Text] [Related]
13. Biochemical basis of malignant hyperpyrexia.
Moulds RF; Denborough MA
Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
[TBL] [Abstract][Full Text] [Related]
14. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
Ording H
Acta Anaesthesiol Scand; 1989 Jul; 33(5):405-8. PubMed ID: 2800978
[TBL] [Abstract][Full Text] [Related]
15. Effect of temperature, time and fascicle size on the caffeine contracture test.
Britt BA; Endrenyi L; Scott E; Frodis W
Can Anaesth Soc J; 1980 Jan; 27(1):1-11. PubMed ID: 7353184
[No Abstract] [Full Text] [Related]
16. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle.
Williams JH; Holland M; Lee JC
Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762
[TBL] [Abstract][Full Text] [Related]
17. Muscle contractures and adenosine triphosphate depletion in porcine malignant hyperthermia.
Gronert GA
Anesth Analg; 1979; 58(5):367-71. PubMed ID: 573559
[TBL] [Abstract][Full Text] [Related]
18. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia in humans--standardization of contracture testing protocol.
Melton AT; Martucci RW; Kien ND; Gronert GA
Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
Ilias WK; Williams CH; Fulfer RT; Dozier SE
Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
